Unknown

Dataset Information

0

Super-sensitive bifunctional nanoprobe: Self-assembly of peptide-driven nanoparticles demonstrating tumor fluorescence imaging and therapy.


ABSTRACT: The development of nanomedicine has recently achieved several breakthroughs in the field of cancer treatment; however, biocompatibility and targeted penetration of these nanomaterials remain as limitations, which lead to serious side effects and significantly narrow the scope of their application. The self-assembly of intermediate filaments with arginine-glycine-aspartate (RGD) peptide (RGD-IFP) was triggered by the hydrophobic cationic molecule 7-amino actinomycin D (7-AAD) to synthesize a bifunctional nanoparticle that could serve as a fluorescent imaging probe to visualize tumor treatment. The designed RGD-IFP peptide possessed the ability to encapsulate 7-AAD molecules through the formation of hydrogen bonds and hydrophobic interactions by a one-step method. This fluorescent nanoprobe with RGD peptide could be targeted for delivery into tumor cells and released in acidic environments such as endosomes/lysosomes, ultimately inducing cytotoxicity by arresting tumor cell cycling with inserted DNA. It is noteworthy that the RGD-IFP/7-AAD nanoprobe tail-vein injection approach demonstrated not only high tumor-targeted imaging potential, but also potent antitumor therapeutic effects in vivo. The proposed strategy may be used in peptide-driven bifunctional nanoparticles for precise imaging and cancer therapy.

SUBMITTER: Xiao H 

PROVIDER: S-EPMC9069314 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Super-sensitive bifunctional nanoprobe: Self-assembly of peptide-driven nanoparticles demonstrating tumor fluorescence imaging and therapy.

Xiao Han H   Zhang Rui R   Fan Xiaobo X   Jiang Xinglu X   Zou Mingyuan M   Yan Xuejiao X   Hao Haiping H   Wu Guoqiu G  

Acta pharmaceutica Sinica. B 20210726 3


The development of nanomedicine has recently achieved several breakthroughs in the field of cancer treatment; however, biocompatibility and targeted penetration of these nanomaterials remain as limitations, which lead to serious side effects and significantly narrow the scope of their application. The self-assembly of intermediate filaments with arginine-glycine-aspartate (RGD) peptide (RGD-IFP) was triggered by the hydrophobic cationic molecule 7-amino actinomycin D (7-AAD) to synthesize a bifu  ...[more]

Similar Datasets

| S-EPMC4132961 | biostudies-literature
| S-EPMC9419478 | biostudies-literature
| S-EPMC9038665 | biostudies-literature
| S-EPMC4021865 | biostudies-literature
| S-EPMC6560097 | biostudies-literature
| S-EPMC4674812 | biostudies-literature
| S-EPMC9254247 | biostudies-literature
| S-EPMC9084454 | biostudies-literature
| S-EPMC9080194 | biostudies-literature
| S-EPMC9769108 | biostudies-literature